These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11783945)

  • 1. PBK/TOPK is a novel mitotic kinase which is upregulated in Burkitt's lymphoma and other highly proliferative malignant cells.
    Simons-Evelyn M; Bailey-Dell K; Toretsky JA; Ross DD; Fenton R; Kalvakolanu D; Rapoport AP
    Blood Cells Mol Dis; 2001; 27(5):825-9. PubMed ID: 11783945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PBK/TOPK in the differential diagnosis of cholangiocarcinoma from hepatocellular carcinoma and its involvement in prognosis of human cholangiocarcinoma.
    He F; Yan Q; Fan L; Liu Y; Cui J; Wang J; Wang L; Wang Y; Wang Z; Guo Y; Huang G
    Hum Pathol; 2010 Mar; 41(3):415-24. PubMed ID: 19954816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDZ-binding kinase/T-LAK cell-originated protein kinase, a putative cancer/testis antigen with an oncogenic activity in breast cancer.
    Park JH; Lin ML; Nishidate T; Nakamura Y; Katagiri T
    Cancer Res; 2006 Sep; 66(18):9186-95. PubMed ID: 16982762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein expression of PDZ-binding kinase is up-regulated in hematologic malignancies and strongly down-regulated during terminal differentiation of HL-60 leukemic cells.
    Nandi A; Tidwell M; Karp J; Rapoport AP
    Blood Cells Mol Dis; 2004; 32(1):240-5. PubMed ID: 14757441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitotic kinase PBK/TOPK as a therapeutic target for adult T‑cell leukemia/lymphoma.
    Ishikawa C; Senba M; Mori N
    Int J Oncol; 2018 Aug; 53(2):801-814. PubMed ID: 29901068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PBK/TOPK promotes tumour cell proliferation through p38 MAPK activity and regulation of the DNA damage response.
    Ayllón V; O'connor R
    Oncogene; 2007 May; 26(24):3451-61. PubMed ID: 17160018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical roles of LGN/GPSM2 phosphorylation by PBK/TOPK in cell division of breast cancer cells.
    Fukukawa C; Ueda K; Nishidate T; Katagiri T; Nakamura Y
    Genes Chromosomes Cancer; 2010 Oct; 49(10):861-72. PubMed ID: 20589935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of PDZ-binding kinase/T-LAK cell-originated protein kinase (PBK/TOPK) in human urinary bladder transitional cell carcinoma.
    Singh PK; Srivastava AK; Dalela D; Rath SK; Goel MM; Bhatt ML
    Immunobiology; 2014 Jun; 219(6):469-74. PubMed ID: 24629784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The A-myb gene is preferentially expressed in tonsillar CD38+, CD39-, and sIgM- B lymphocytes and in Burkitt's lymphoma cell lines.
    Golay J; Erba E; Bernasconi S; Peri G; Introna M
    J Immunol; 1994 Jul; 153(2):543-53. PubMed ID: 8021494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PBK/TOPK: A Therapeutic Target Worthy of Attention.
    Han Z; Li L; Huang Y; Zhao H; Luo Y
    Cells; 2021 Feb; 10(2):. PubMed ID: 33670114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and phosphorylation of TOPK during spermatogenesis.
    Fujibuchi T; Abe Y; Takeuchi T; Ueda N; Shigemoto K; Yamamoto H; Kito K
    Dev Growth Differ; 2005 Dec; 47(9):637-44. PubMed ID: 16316408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
    Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
    J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression.
    Wolf J; Pawlita M; Bullerdiek J; zur Hausen H
    Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Myc and E2F1 drive PBK/TOPK expression in high-grade malignant lymphomas.
    Hu F; Gartenhaus RB; Zhao XF; Fang HB; Minkove S; Poss DE; Rapoport AP
    Leuk Res; 2013 Apr; 37(4):447-54. PubMed ID: 23237560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma.
    Ohashi T; Komatsu S; Ichikawa D; Miyamae M; Okajima W; Imamura T; Kiuchi J; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
    Br J Cancer; 2017 Jan; 116(2):218-226. PubMed ID: 27898655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a MAPKK-like protein kinase TOPK.
    Matsumoto S; Abe Y; Fujibuchi T; Takeuchi T; Kito K; Ueda N; Shigemoto K; Gyo K
    Biochem Biophys Res Commun; 2004 Dec; 325(3):997-1004. PubMed ID: 15541388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PBK/TOPK, a proliferating neural progenitor-specific mitogen-activated protein kinase kinase.
    Dougherty JD; Garcia AD; Nakano I; Livingstone M; Norris B; Polakiewicz R; Wexler EM; Sofroniew MV; Kornblum HI; Geschwind DH
    J Neurosci; 2005 Nov; 25(46):10773-85. PubMed ID: 16291951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of CD150/SLAMF1 in normal and malignant B cells on the different stages of maturation.
    Gordiienko IM; Shlapatska LM; Kovalevska LM; Sidorenko SP
    Exp Oncol; 2016 Jun; 38(2):101-7. PubMed ID: 27356578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human peripheral gamma delta T cells are stimulated by Daudi Burkitt's lymphoma and not by any other Burkitt's lymphoma tested.
    Kaur I; de Jong J; Schell K; Hank J; Fisch P; Sondel PM
    Cell Immunol; 1994 Jun; 156(1):54-61. PubMed ID: 8200042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of PDZ-binding kinase (PBK) is regulated by cell cycle-specific transcription factors E2F and CREB/ATF.
    Nandi AK; Rapoport AP
    Leuk Res; 2006 Apr; 30(4):437-47. PubMed ID: 16171862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.